Barnton, United Kingdom

Paul Elvin

This inventor holds 1 USPTO granted patent. Top assignee: Zeneca Limited. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Elvin. Retrieved from https://idiyas.com/inventor/paul-elvin-7n7vvrpc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paul Elvin

Introduction

Paul Elvin is a notable inventor based in Barnton, GB. He has made significant contributions to the field of genetics, particularly in the study of cystic fibrosis. His work has implications for understanding genetic disorders and developing potential treatments.

Latest Patents

One of Paul Elvin's key patents is related to yeast artificial chromosomes containing DNA encoding the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This patent describes yeast artificial chromosomes (YACs) that facilitate detailed analysis of both coding and non-coding regions of the CFTR gene. The YACs enable the determination of cystic fibrosis alleles in DNA samples from individuals, which is crucial for genetic research and diagnostics.

Career Highlights

Paul Elvin is associated with Zeneca Limited, a company known for its research and development in pharmaceuticals and biotechnology. His work at Zeneca has allowed him to contribute to advancements in genetic research and therapeutic development.

Collaborations

Throughout his career, Paul has collaborated with esteemed colleagues such as Rakesh Anand and Alexander Fred Markham. These collaborations have further enriched his research and innovation in the field.

Conclusion

Paul Elvin's contributions to genetic research, particularly through his patent on yeast artificial chromosomes, highlight his role as an influential inventor in the biotechnology sector. His work continues to pave the way for advancements in understanding and treating genetic disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…